CARD9 deficiencies linked to impaired neutrophil functions against Phialophora verrucosa

Mycopathologia
Pin LiangRuoyu Li

Abstract

Caspase recruitment domain-containing protein 9 (CARD9) is an adaptor molecule that is critical for NF-κB activation and forms a complex with B cell lymphoma 10 and mucosa-associated lymphoid tissue lymphoma translocation gene 1 that mediates C-type lectin receptors (CLRs)-triggered intracellular signaling during antifungal immunity. However, the role of CARD9 in the host defense against Phialophora verrucosa (P. verrucosa) infection remains to be elucidated. In the present study, we investigated the functions of polymorphonuclear neutrophils (PMNs) from patients with CARD9 deficiencies against P. verrucosa. By isolating PMNs from patients and healthy blood donors and subsequently challenging the cells with P. verrucosa, we demonstrated that, compared with healthy donors, CARD9-deficient PMNs exhibited defects in P. verrucosa killing and pro-inflammatory cytokine productions, which can be rescued in the presence of serum; however, the CARD9-deficient PMNs exhibited normal reactive oxygen species generation and phagocytotic ability. In conclusion, our results indicate that CARD9 is indispensable for P. verrucosa killing by PMNs, and serum opsonization acts as a CARD9-independent way, which could be a promising immunotherapy in t...Continue Reading

References

Jan 1, 1983·Journal of the American Academy of Dermatology·M R McGinnis
Jul 1, 1981·Physiological Reviews·K Aukland, G Nicolaysen
Jan 1, 1995·Immunology Today·M A Cassatella
Oct 1, 1993·The Clinical Investigator·M Baggiolini
Sep 27, 2000·FEMS Microbiology Letters·H Peltroche-LlacsahuangaG Haase
Jan 4, 2001·Immunological Reviews·P ScapiniM A Cassatella
Feb 25, 2005·Journal of Leukocyte Biology·Lisa C ParkerIan Sabroe
Jun 2, 2009·Frontiers in Bioscience (Scholar Edition)·Volker Vielhauer, Hans-Joachim Anders
Oct 30, 2009·The New England Journal of Medicine·Erik-Oliver GlockerBodo Grimbacher
Feb 26, 2013·Nature Reviews. Immunology·Elzbieta Kolaczkowska, Paul Kubes
Sep 3, 2013·International Immunopharmacology·Krisztina FutosiAttila Mócsai
Oct 18, 2013·The New England Journal of Medicine·Fanny LanternierAnne Puel
Nov 16, 2013·The Journal of Allergy and Clinical Immunology·Xiaowen WangRuoyu Li
Jul 2, 2014·Clinical Microbiology Reviews·Seyedmojtaba SeyedmousaviG Sybren de Hoog
Jul 25, 2014·The Journal of Infectious Diseases·Fanny LanternierAnne Puel

❮ Previous
Next ❯

Citations

Jun 22, 2019·Journal of Clinical Immunology·F Queiroz-TellesAnete S Grumach
Jun 18, 2020·Cellular Microbiology·Theodore J KottomAndrew H Limper
Sep 4, 2015·The Journal of Immunology : Official Journal of the American Association of Immunologists·Natasha WhibleySarah L Gaffen
Apr 20, 2016·Frontiers in Cellular and Infection Microbiology·Rebecca A Drummond, Michail S Lionakis
Dec 7, 2018·Medical Mycology Journal·Yuhko SuzukiHikaru Kume
Mar 11, 2016·Journal of Clinical Immunology·Ana Karina Alves de MedeirosMelissa Dullaers
Jan 21, 2018·Cell Death & Disease·Xiaoming ZhongZhiwen Yang
Mar 19, 2020·Frontiers in Cellular and Infection Microbiology·Richard M Merkhofer, Bruce S Klein
Nov 20, 2016·Clinical Microbiology Reviews·Flavio Queiroz-TellesThomas J Walsh
Aug 22, 2018·Frontiers in Immunology·Rebecca A DrummondMichail S Lionakis
Oct 26, 2016·JCI Insight·Nikolaus RieberMichail S Lionakis
Nov 2, 2015·The Journal of Allergy and Clinical Immunology·Christina GavinoDonald C Vinh
Jan 26, 2021·Mediators of Inflammation·Ruanmei ShengXuemin Wang
Nov 13, 2017·Current Opinion in Microbiology·Juan LiAnne Puel
Jun 1, 2021·Medical Mycology Journal·Junko HattaTakashi Mochizuki
Nov 13, 2021·International Journal of Dermatology·Marwan OsmanMonzer Hamze

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.